NTRB

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Nutriband Inc

NASDAQ | NTRB

7.00

USD

$0.00

(

0.00%

)

At Close (As of Oct 23, 2025)

$86.98M

Market Cap

-

P/E Ratio

-2.89

EPS

$11.78

52 Week High

$3.72

52 Week Low

HEALTHCARE

Sector

NTRB Chart

Recent Chart
Price Action

NTRB Technicals

Tags:

NTRB Earnings

Yearly Income Statement (As of Jan 31, 2025)

Field Value (USD)
Gross Profit $699K
Total Revenue $2.1M
Cost Of Revenue $1.4M
Costof Goods And Services Sold $1.4M
Operating Income -$6.7M
Selling General And Administrative $4.3M
Research And Development $3.1M
Operating Expenses $7.4M
Investment Income Net -
Net Interest Income $170K
Interest Income $192K
Interest Expense $21K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $285K
Income Before Tax -$10M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$10M
Comprehensive Income Net Of Tax -
Ebit -$10M
Ebitda -$10M
Net Income -$10M

Revenue & Profitability

Earnings Performance

NTRB Financials

yearly Balance Sheet (As of Jan 31, 2025)

Field Value (USD)
Total Assets $7.5M
Total Current Assets $4.8M
Cash And Cash Equivalents At Carrying Value $4.3M
Cash And Short Term Investments $4.3M
Inventory $212K
Current Net Receivables $74K
Total Non Current Assets $2.7M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $261K
Intangible Assets Excluding Goodwill $261K
Goodwill $1.7M
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $196K
Other Non Current Assets -
Total Liabilities $1M
Total Current Liabilities $983K
Current Accounts Payable $699K
Deferred Revenue -
Current Debt -
Short Term Debt $128K
Total Non Current Liabilities $58K
Capital Lease Obligations $0
Long Term Debt $58K
Current Long Term Debt $128K
Long Term Debt Noncurrent -
Short Long Term Debt Total $186K
Other Current Liabilities $699K
Other Non Current Liabilities -
Total Shareholder Equity $6.4M
Treasury Stock -
Retained Earnings -$38M
Common Stock $11K
Common Stock Shares Outstanding $11M

yearly Cash Flow (As of Jan 31, 2025)

Field Value (USD)
Operating Cashflow -$4.6M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $285K
Capital Expenditures $92K
Change In Receivables -
Change In Inventory -$43K
Profit Loss -
Cashflow From Investment -$92K
Cashflow From Financing $8.5M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$149K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$10M

yearly Income Statement (As of Jan 31, 2025)

Field Value (USD)
Gross Profit $699K
Total Revenue $2.1M
Cost Of Revenue $1.4M
Costof Goods And Services Sold $1.4M
Operating Income -$6.7M
Selling General And Administrative $4.3M
Research And Development $3.1M
Operating Expenses $7.4M
Investment Income Net -
Net Interest Income $170K
Interest Income $192K
Interest Expense $21K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $285K
Income Before Tax -$10M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$10M
Comprehensive Income Net Of Tax -
Ebit -$10M
Ebitda -$10M
Net Income -$10M

NTRB News

NTRB Profile

Nutriband Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Nutriband Inc. is an innovative biotechnology company based in Orlando, Florida, specializing in advanced transdermal drug delivery systems. Leveraging proprietary technology, Nutriband is committed to developing non-invasive pharmaceutical formulations that improve patient adherence and therapeutic outcomes. With a robust focus on research and development, the company is well-positioned to capitalize on the growing demand for alternative treatment modalities in the pharmaceutical sector, highlighting its potential for significant market growth and influence in the industry.

YYAI
-45.90%
$0.10
YDKG
+4.55%
$0.07
SCNX
+120.47%
$1.26
BYND
-3.07%
$3.47
VHAI
0.00%
$0.00
F
-0.83%
$12.32
CGBS
-39.47%
$0.03
RGTI
+10.91%
$39.99
VTYX
+92.09%
$7.41
BURU
-7.58%
$0.33
QBTS
+16.12%
$31.69
AIRE
+26.54%
$0.90
NOK
+10.99%
$6.16
AXDX
-61.36%
$0.03
WTO
-3.92%
$0.07
ADAP
+9.51%
$0.07
IONZ
-16.09%
$3.91
TSLA
-0.61%
$436.29
GPUS
+4.79%
$0.38
PLTR
-3.31%
$175.49
AREB
+29.27%
$2.77
NVDA
+1.05%
$182.17
AAL
+4.59%
$12.64
RIG
+6.24%
$3.63
QUBT
-7.06%
$14.87
MSAI
+44.79%
$0.96
PFE
-0.52%
$24.72
T
-3.40%
$24.68
IONQ
+6.62%
$59.12
RBNE
+20.42%
$1.52
RMBL
+60.50%
$3.21
BITF
+3.88%
$4.09
ADD
-25.47%
$0.05
RGTZ
-13.53%
$16.16
SGBX
+25.30%
$2.85
PLUG
+0.92%
$2.94
VIVK
+14.62%
$0.28
SRM
+53.27%
$10.30
INTC
+1.05%
$37.31
SMCI
-6.59%
$49.04
TLRY
+2.75%
$1.49
CUTR
-10.19%
$0.09
WLGS
-5.57%
$0.04
QS
+9.09%
$14.81
DNN
+0.73%
$2.74
SOFI
+3.86%
$28.24
TNGX
-9.35%
$7.84
ETWO
0.00%
$3.30
IBIO
-10.07%
$1.25
LAES
+6.45%
$5.74
ABEV
-0.19%
$2.19
AFMD
-34.94%
$0.18
RF
+0.06%
$24.12
PLTD
+3.41%
$6.97
BTE
+2.71%
$2.27
CAN
+4.18%
$1.77
NEHC
-12.47%
$3.79
DVLT
+9.11%
$2.33
VZ
-2.82%
$38.67
BBD
+1.36%
$3.34
TE
-9.97%
$3.70
GRAB
+1.51%
$5.70
AMD
+1.35%
$233.36
OPI
-16.97%
$0.20
KLG
-9.05%
$13.35
JOBY
+1.13%
$15.64
GRYP
-10.38%
$1.38
ETHD
-4.51%
$3.91
BTG
-0.17%
$5.20
MODV
-25.22%
$0.43
UUUU
-4.11%
$21.80
ACHR
-0.04%
$10.85
DKNG
+3.21%
$34.70
ONDS
+5.48%
$7.11
EONR
-13.58%
$0.54
NIO
+0.73%
$6.89
NVTS
+2.88%
$13.99
BTBT
-0.05%
$3.58
VLY
+5.77%
$10.71
SOUN
+3.46%
$18.37
MARA
+2.23%
$19.57
ELBM
-2.40%
$1.62
RXRX
-0.78%
$5.70
KDLY
-4.25%
$0.72
PBR
+1.66%
$11.92
RANI
-9.31%
$2.19
IREN
+7.27%
$55.60
NMRA
+29.83%
$2.22
KMI
-3.15%
$26.69
ARCT
-50.17%
$11.54
APLD
+6.30%
$32.54
SAND
-6.04%
$12.12
LUV
-7.44%
$31.24
CIFR
+4.53%
$16.84
AMC
+0.72%
$2.77
SHOT
-74.37%
$0.39
WBD
+3.45%
$21.24
EPWK
-3.34%
$0.07
ZAPP
-46.30%
$0.15
DNUT
+1.32%
$4.08
YYAI
-45.90%
$0.10
YDKG
+4.55%
$0.07
SCNX
+120.47%
$1.26
BYND
-3.07%
$3.47
VHAI
0.00%
$0.00
F
-0.83%
$12.32
CGBS
-39.47%
$0.03
RGTI
+10.91%
$39.99
VTYX
+92.09%
$7.41
BURU
-7.58%
$0.33
QBTS
+16.12%
$31.69
AIRE
+26.54%
$0.90
NOK
+10.99%
$6.16
AXDX
-61.36%
$0.03
WTO
-3.92%
$0.07
ADAP
+9.51%
$0.07
IONZ
-16.09%
$3.91
TSLA
-0.61%
$436.29
GPUS
+4.79%
$0.38
PLTR
-3.31%
$175.49
AREB
+29.27%
$2.77
NVDA
+1.05%
$182.17
AAL
+4.59%
$12.64
RIG
+6.24%
$3.63
QUBT
-7.06%
$14.87
MSAI
+44.79%
$0.96
PFE
-0.52%
$24.72
T
-3.40%
$24.68
IONQ
+6.62%
$59.12
RBNE
+20.42%
$1.52
RMBL
+60.50%
$3.21
BITF
+3.88%
$4.09
ADD
-25.47%
$0.05
RGTZ
-13.53%
$16.16
SGBX
+25.30%
$2.85
PLUG
+0.92%
$2.94
VIVK
+14.62%
$0.28
SRM
+53.27%
$10.30
INTC
+1.05%
$37.31
SMCI
-6.59%
$49.04
TLRY
+2.75%
$1.49
CUTR
-10.19%
$0.09
WLGS
-5.57%
$0.04
QS
+9.09%
$14.81
DNN
+0.73%
$2.74
SOFI
+3.86%
$28.24
TNGX
-9.35%
$7.84
ETWO
0.00%
$3.30
IBIO
-10.07%
$1.25
LAES
+6.45%
$5.74
ABEV
-0.19%
$2.19
AFMD
-34.94%
$0.18
RF
+0.06%
$24.12
PLTD
+3.41%
$6.97
BTE
+2.71%
$2.27
CAN
+4.18%
$1.77
NEHC
-12.47%
$3.79
DVLT
+9.11%
$2.33
VZ
-2.82%
$38.67
BBD
+1.36%
$3.34
TE
-9.97%
$3.70
GRAB
+1.51%
$5.70
AMD
+1.35%
$233.36
OPI
-16.97%
$0.20
KLG
-9.05%
$13.35
JOBY
+1.13%
$15.64
GRYP
-10.38%
$1.38
ETHD
-4.51%
$3.91
BTG
-0.17%
$5.20
MODV
-25.22%
$0.43
UUUU
-4.11%
$21.80
ACHR
-0.04%
$10.85
DKNG
+3.21%
$34.70
ONDS
+5.48%
$7.11
EONR
-13.58%
$0.54
NIO
+0.73%
$6.89
NVTS
+2.88%
$13.99
BTBT
-0.05%
$3.58
VLY
+5.77%
$10.71
SOUN
+3.46%
$18.37
MARA
+2.23%
$19.57
ELBM
-2.40%
$1.62
RXRX
-0.78%
$5.70
KDLY
-4.25%
$0.72
PBR
+1.66%
$11.92
RANI
-9.31%
$2.19
IREN
+7.27%
$55.60
NMRA
+29.83%
$2.22
KMI
-3.15%
$26.69
ARCT
-50.17%
$11.54
APLD
+6.30%
$32.54
SAND
-6.04%
$12.12
LUV
-7.44%
$31.24
CIFR
+4.53%
$16.84
AMC
+0.72%
$2.77
SHOT
-74.37%
$0.39
WBD
+3.45%
$21.24
EPWK
-3.34%
$0.07
ZAPP
-46.30%
$0.15
DNUT
+1.32%
$4.08
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.